Summary: Marc Gunther examines the potential applications of MDMA-assisted therapy in a variety of contexts, claiming that “MDMA is having a moment.” Along with an assessment of the “impressive results” of MAPS’ first Phase 3 clinical trial of MDMA-assisted therapy for PTSD, Gunther shares that psychedelic researchers and “experienced users” alike “say that the drug could be an effective way to treat other psychological ailments, while improving the health and happiness of so-called ‘healthy normals.'”
Could MDMA become one of the greatest drugs ever?
It could help people suffering from trauma, people who drink too much, couples in therapy and, importantly, the rest of us.
Originally appearing here.